Showing results (1-10 of 1,964) with videos related to

Sort By:
Pageof 197
Progress in Cardiovascular Diseases|July 1, 1993
The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarctionS M Jafri, B Zarowitz, S Goldstein, et al.
Current Problems in Cardiology|September 1, 1991
Medical therapy after acute myocardial infarctionS M Jafri, M Gheorghiade, H Mahdyoon, et al.
American Heart Journal|July 1, 1997
Effects of warfarin on markers of hypercoagulability in patients with heart failureS M Jafri, E F Mammen, J Masura, et al.
The American Journal of Cardiology|February 1, 1990
Effects of cigarette smoking and propranolol in survivors of acute myocardial infarctionS M Jafri, B C Tilley, R Peters, et al.
American Heart Journal|October 1, 1987
Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failureB S Burlew, M Gheorghiade, S M Jafri, et al.
The American Journal of Cardiology|February 1, 1986
Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failureS M Jafri, B S Burlew, A D Goldberg, et al.
European Heart Journal|February 1, 1993
Platelet function, thrombin and fibrinolytic activity in patients with heart failureS M Jafri, T Ozawa, E Mammen, et al.
Journal of Molecular and Cellular Cardiology|November 1, 1992
Mitochondrial abnormalities in myocardium of dogs with chronic heart failureH N Sabbah, V Sharov, J M Riddle, et al.
The American Journal of Cardiology|April 1, 1992
Circadian variation in platelet function in healthy volunteersS M Jafri, M VanRollins, T Ozawa, et al.
The American Journal of Cardiology|May 1, 1987
Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathyS M Jafri, B S Burlew, A D Goldberg, et al.
Pageof 197